protease activated receptor-1 antagonist (LG Life Sciences)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameprotease activated receptor-1 antagonist (LG Life Sciences)
Drug Alias NamePAR-1 inhibitor (LG Life Sciences)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease-activated receptor-1 antagonistsFactor IIa inhibitors
TargetsProtease-activated receptor-1Prothrombin
Therapy Area/IndicationsVenous ThrombosisAtherosclerosisAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLg Chemical Ltd
Active IndicationsN/A
Inactive IndicationsVenous ThrombosisAtherosclerosisAtrial Fibrillation

Other Information

ATC CodeN/A
Related LinksN/A